Personal Information
- Full Name: Dr. Achal Mishra
- Mobile Number: 9691054057
- EmailID: achal.mishra@ggu.ac.in
- Designation: Assistant Professor
Qualification
-
2019PhD
Banasthali VIdyapith
-
2008M.Pharm
Biju Patnaik University of Technology
-
2005B.Pharm
Guru Ghasidas University
Experience
-
2023 - PresentAssistant Professor
Guru Ghasidas Vishwavidyalaya
-
2021 - 2023Professor
Shri Shankaracharya Technical Campus Previously known as Shri Shankaracharya Institute of Pharmaceutical Science
-
2018 - 2015Assistant Professor
Shri Shankaracharya Technical Campus Previously known as Shri Shankaracharya Institute of Pharmaceutical Science
-
2015 - 2021Ass0ciate Professor
Shri Shankaracharya Technical Campus Previously known as Shri Shankaracharya Institute of Pharmaceutical Science
Research Projects
QSAR analysis of some derivatives of quinoxaline as antimalarial agent
Completed Amount: ₹4.00
Funding Agency: Chhattisgarh Council of Science & Technology (CGCOST)
Duration : 27:01:2015 - 12:06:2018
Publications
Post-operative Wound Healing Efficacy of Eucalyptus Camaldulensis Phenolic-rich Extracts Incorporated Hydrogel With Enhanced Antioxidant, Antibacterial, and Anti-inflammatory Activities.
1. Singh S, Syukri DM, Ushir YV, Mishra A, Ontong JC, Nwabor OF, Darekar SM, Samee W, Chidrawar VR, Chittasupho C.
Publication Type: Journal Article (International)
Journal: Journal of Polymers and the Environment
Volume: 7
Year: 2024
Pages: 1-26
DOI: https://doi.org/10.1007/s10924-024-03427-x
Impact Factor: 5.00
Decoding the molecular Symphony: Unravelling neurologically crucial GSK-3 inhibition through 2D QSAR modelling with MLR, PLS, and ANN approaches
Chauhan N, Paliwal S, Sharma S, Jain S, Madan K, Paliwal A, Sharma P, Mishra A, Mohite P, Chidrawar V, Singh S.
Publication Type: Journal Article (International)
Journal: Results in Chemistry
Volume: 8
Year: 2024
Pages: 101595
DOI: https://doi.org/10.1016/j.rechem.2024.101595
Impact Factor: 4.20
In-silico molecular docking and screening of Costus specious bioactive compounds as potential herb in management of diabetes mellitus
3. Mishra T, Verma S, Verma VS, Mishra A, Jeswani G, Sahu D, Mohite P, Chidrawar VR, Singh S
Publication Type: Journal Article (International)
Journal: Vegetos
Volume: 1
Year: 2024
Pages: 1-4
DOI: https://doi.org/10.1007/s42535-024-01034-8
BACE1 inhibitors: A promising therapeutic approach for the management of Alzheimer’s disease
Arya R, Jain S, Paliwal S, Madan K, Sharma S, Mishra A, Tiwari P, Kadiri SK.
Publication Type: Journal Article (International)
Journal: Asian Pacific Journal of Tropical Biomedicine
Volume: 14(9)
Year: 2024
Pages: 369-381
DOI: DOI: 10.4103/apjtb.apjtb_192_24
Impact Factor: 1.70
Pyrrole: An Essential Framework in the Development of Therapeutic Agents and Insightful Analysis of Structure‐Active Relationships.
Sahu B, Sahu R, Gidwani B, Mishra A
Publication Type: Journal Article (International)
Journal: Chemistry Select
Volume: 9(31)
Year: 2024
Pages: e202401604
DOI: https://doi.org/10.1002/slct.202401604
Impact Factor: 2.00
New Investigational Drug’s Targeting Various Molecular Pathways for Treatment of Cervical Cancer: Current Status and Future Prospects
Kumar Kore R, Shirbhate E, Singh V, Mishra A, Veerasamy R, Rajak H
Publication Type: Journal Article (International)
Journal: Cancer Investigation
Volume: 42
Year: 2024
Pages: 626-642
DOI: https://doi.org/10.1080/07357907.2024.2373841
Impact Factor: 1.90
In Silico Design and Molecular Docking Study of Some Novel Flutamide Analogues in the Management of Prostate Cancer
Gupta AK, Mishra A, Jain SK
Publication Type: Journal Article (National)
Journal: Current Science
Volume: 126(4)
Year: 2024
Pages: 452
DOI: 10.18520/cs/v126/i4/452-462
Impact Factor: 1.10
Nephroprotective Activity of Dibenzo-alpha-Pyrone Derivatives in Gentamicin-Induced Nephrotoxicity and Oxidative Stress in Rats
8. Sawhney SK, Singh M, Puri D, Hazarika S, Mishra A
Publication Type: Journal Article (National)
Journal: . Indian journal of pharmaceutical education and research
Volume: 58(2)
Year: 2024
Pages: 618-23
DOI: 10.5530/ijper.58.2.69
Impact Factor: 0.80